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Septicemia is a disease with high mortality and morbidity.  Most patients die within 48 h after infection 
because directed treatment can only start after the bacterium is identified as gram positive or gram 
negative.  This may take up to 72 h.  Early identification of the causative pathogen can therefore 
decrease the high mortality rate following infection. The aim was to identify possible metabolic markers 
of gram positive and gram negative septicemia in appropriately infected baboons.  Ten baboons, 
anaesthetised with ketamine hydrochloride and pentobarbitone for 24 h, were used in this pilot study.  
Blood and urine samples were collected at various intervals during the 24 h.  Four baboons were 
inoculated with S. pyogenes H305 and four with E. coli O111:B4. Two baboons served as controls.  Acyl 
carnitine, amino acids, organic acids, very long chain fatty acids, glucose, pyruvate and lactate were 
measured in blood plasma and in urine using standardised methods.  No metabolic markers could 
distinguish between gram positive and gram negative septicemia.  α-Amino-adipic acid, citramalic acid 
and xanthurenic acid, produced only by bacteria, show promise. Alanine and glycine increased 
significantly over 24 h and can be used as diagnostic markers and perhaps as markers of disease 
progression. In conclusion, (in PDF file it is conclusively) metabolites can be used to diagnose 
septicemia and possibly its progression, but not to distinguish between gram positive and gram 
negative septicemia. 
 





Septicaemia is caused by either Gram positive or Gram 
negative bacteria in the circulation (Martin et al., 2003) 
where they actively multiply and overwhelm the immune 
system. This can then rapidly develop into septic shock 
and death (Van Amersfoort et al., 2003). Over the last 22 
years, the incidence of septicaemia increased at a rate of 
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of vast technical development in intensive care units and 
advanced support treatments (Bone, 1993; Riedemann et 
al., 2003). Mortality depends on the type, site and extent 
of the organism involved, how early the patient is hospi-
talized, diagnosed and how quickly the appropriate 
treatment is started (Martin et al., 2003). Organ failure 
also determines the prognoses; the risk of death in-
creases with increasing numbers of failing organs (Das, 
2000; Levy et al., 2003; Watson et al., 2003). It is 
important to note that more than 50% of patients with 
sepsis die during the first 48 h after infection (Bone, 
1993). 
The problem to adequately manage patients with septi-
caemia and the reason for the relatively high mortality is 






Current standard microbiological techniques identify 
infecting organisms after culture of a blood sample/isolate 
in conditions suitable for replication of the infectious 
bacterium. This may be difficult if patients already receive 
antibiotics (Gao et al., 2008). Preliminary classification is 
usually done within 24 h, with full species identification 
and antimicrobial sensitivity data becoming available only 
48 to 72 h after blood sampling. The slowness of the 
investigation usually mandates the use of broad-
spectrum antibiotics while awaiting results (Jansen et al., 
2000; Mishra et al., 2006; Gao et al., 2008). Only after it 
is known if the causing bacterium is Gram positive or 
Gram negative can the specific antibiotic treatment start. 
In addition, drug selection not only depends on the cau-
sing bacterium, but also on the site or presumed site of 
infection, the place from where the infection was 
acquired, the underlying disease status of the patient and 
possible drug toxicities and drug resistance all of which 
complicates the matter further (Bone, 1993; Watson et 
al., 2003). 
Biomarkers provide a fresh approach to diagnose 
infection, to assess its severity and to design a specific 
treatment response (Mueller et al., 2008). In septicaemia, 
products of activation of the immune response lead to 
leukocyte recruitment at the site of infections, where they 
start an inflammatory response, leading to an increase in 
biomarkers of the immune system. Established bio-
markers, especially procalcitonin (PCT) and to a lesser 
extent, C-reactive protein (CRP), can improve the diag-
nostic and prognostic assessment of bloodstream 
infections. It is, however, important to note that these 
biomarkers can currently only be used as complementary 
tools to reinforce a clinical diagnostic workup (Mueller et 
al., 2008). PCT is currently preferred as a biomarker for 
sepsis because of several advantages that it has over 
other inflammatory markers. These include an earlier 
increase in response to an infection that is maintained 
even with immunosuppressive medication, a better 
negative predictive value and a better correlation with 
outcome (mortality). CRP on the other hand, increases 
relatively late in the infectious process. It is, however, 
attenuated by the concomitant use of steroids and may 
be elevated as a direct consequence of a malignancy 
rather than from an infection (Dahaba et al., 2006; Müller 
et al., 2007; Monneret et al., 2008). In addition to clinical 
and microbiological parameters, PCT may further help 
differentiate blood contamination from bloodstream 
infection (Müller et al., 2007; Mueller et al., 2008). PCT 
levels also increase far less than the CRP levels while 
the period of unspecific induction is much shorter. PCT is 
therefore the better choice to diagnose sepsis and 
infection early after surgery. One must bear in mind that, 
contrary to previous studies, established cut-off values 
only indicate the risk to develop complications during the 
further course of the disease, and not the actual sensi-
tivity or specificity to diagnose sepsis (Meisner et al., 
2006).  




Limitations of every biomarker include false-positive 
and false-negative results, and the time kinetics of the 
test. It is possible to obtain false-positive results in 
patients post-operatively who may present with very high 
levels of PCT and CRP and no signs of infection. This is 
also possible during post-traumatic periods and after 
mechanical trauma. Emphysema is associated with 
variable increased levels of CRP, but relatively low PCT 
levels. Caution is also required in settings where infection 
with coagulase negative staphylococci or certain 
intracellular bacteria are suspected. These are often 
associated with low PCT concentrations and may be 
overlooked using standard assays. PCT and CRP are 
also independently increased following cardiogenic shock 
(Meisner et al., 2006; Mueller et al., 2008). A major 
limitation of these biomarkers is that it cannot determine if 
the infective organism is Gram positive or Gram negative 
and also the associated patterns of antibiotic suscepti-
bility (Müller et al., 2007; Mueller et al., 2008). 
Several other techniques that can speed up the 
identification of infecting organisms are at different stages 
of development. Most of these techniques use the poly-
merase chain reaction (PCR) or fluorescent in situ 
hybridization. Although these methods are fast and 
accurate, routine bacteriological analysis still rely on clas-
sical culturing techniques which is still the mainstay of 
distinguishing between Gram positive and Gram negative 
bacteria (Jansen et al., 2000; Llewellyn and Cohen, 2007; 
Müller et al., 2007). It is theoretically possible to do PCR-
based amplification of sufficient magnitude to detect low 
copy numbers of DNA sequences, thereby eliminating the 
requirement for an initial period of standard culture. 
However, the use of these techniques is limited by diffi-
culties in differentiating between contaminants and non-
living or degraded bacteria from clinically relevant 
isolates. Infrared vibration spectroscopy allows the iden-
tification of bacterial specific proteins in whole blood. This 
emerging technique does not require amplification or 
extraction of the proteins. Although none of these 
methods have been evaluated extensively in clinical 
practice, they may offer potential advantages. First, they 
can enable the earlier use of antibiotics with narrower 
spectra, but known efficacy, against a particular 
organism. Second, they promote better understanding of 
the heterogeneity of infection in sepsis. Third, they may 
also enable the use of some of the specific anti-mediator 
therapies that are being investigated (Gao et al., 2008). It 
must also be noted that not all pathology laboratories 
have PCR and/or in situ hybridization readily available. 
It is clear that the methods currently in use to diagnose 
septicaemia and to differentiate between Gram positive 
and Gram negative bacteria is either slow, which delays 
appropriate treatment, or, the new approaches using 
biomarkers, PCR or infrared vibration spectrometry are 
still in their development phase. There is thus still scope 
to investigate other approaches to quickly diagnose 
septicaemia and to differentiate between disease causing  
 




bacteria. The hypothesis in this pilot study is that infection 
with bacteria will quickly affect the metabolism in infected 
individuals and that this will change the metabolic profile. 
We further hypothesised that Gram positive and Gram 
negative bacteria may affect the metabolism in the host 
differently and that this can be measured in the 
metabolite profile. We tested the hypotheses in baboons 
(Papio ursinus) that were inoculated with either E. coli 
(O111:B4; Gram negative) or Streptococcus pyogenes 
(H305; Gram positive). It was postulated that “different 
microbes may induce a distinct response in various 
organs, resulting in a variable repertoire of circulating 
biomarkers and mediators” (Mueller et al., 2008). Blood 
and urine were collected at regular intervals during the 








Ten healthy baboons (Papio ursinus), weighing between 5 and 9 
kg, were used in a study approved by the Ethics Committee of the 
North-West University (project 03D15) in accordance with the 
National Code for animal use in research, education, diagnosis and 
testing of drugs and related substances in South Africa (South 
African Medical Research Council, 2004). Ketamine hydrochloride 
(8 to 10 mg/kg) was used to enable handling. The baboons were 
intubated and connected to a ventilator (FiO2 of 0.25 ± 0.02, Servo 
ventilator 900C, Siemens-Elma, Sweden). General anaesthesia 
was maintained for 24 h with pentobarbitone (2 to 5 mg/kg) and 
halothane. Blood for analysis was collected from the femoral artery 
through a permanent catheter that was placed to ease blood 
collection. The baboons were then infused with either saline (sham 
group; n = 2), serum resistant E. coli O111:B4 (1.5 x 10
7
 CFU/kg in 
saline; n = 4) or S. pyogenes H305 (1.5 x 10
8
 CFU/kg in saline; n = 
4) over 2 h, followed by a monitoring period of 22 h (total length of 
experiment 24 h). Blood samples were collected at time 0 and 
again after 4, 8, 16 and 24 h. Urine samples were collected before 
inocculation and again after 4, 8, 12, 16, 20 and 24 h using an 
urinary catheter placed in the bladder. Urine samples were 
immediately frozen at -80°C. While anaesthetized, the animals 
received an infusion of at least 5 ml/kg/h saline to keep pulmonary 
wedge pressure stable in order to avoid hypovoleamia as a 
complicating factor. The pulmonary wedge pressure was measured 
continuously using a catheter placed in the pulmonary artery. At the 
end the treatment, the animal was euthanised by intravenous 





Electron spray tandem mass spectrometry, Micromass Quatro 
micro
TM
 API (Chemetrix, Midrand, South Africa) was used to 
quantify acylcarnitines in butylated urine samples as described in 
Matern (2008). Amino acid quantification was done on serum and 
urine samples. The amino acids were extracted using the EZ: 
faast
TM 
kit (Separations KGO-7166, Randburg, South Africa) 
according to the instructions of the manufacturers. The amino acids 
were analysed and quantified using a Hewlett-Packard model 6890/ 
5973 GC–MS system (Chemetrix, Midrand, South Africa) equipped 
with a Zebron ZB-AAA GC amino acid analysis GC column (10 m x 
0.25 mm) as described by Duran (2008).  





described (Rinaldo, 2008). A Hewlett-Packard model 5880/5988A 
GC–MS system (Chemetrix, Midrand, South Africa) equipped with a 
MN30962-52 fused silica capillary column (32 m x 0.32 mm x 0.25 
µm) (SMM Instruments, Johannesburg, South Africa). Very long 
chain fatty acids in plasma was extracted and quantified using a 
Hewlett-Packard model 6890/5973 GC–MS system (Chemetrix, 
Midrand, South Africa) equipped with a 122-0132DB 1ms capillary 
column (30 m x 0.25 mm x 0.25 µm) (SMM Instruments, 
Johannesburg, South Africa) as described (Wanders and Duran, 
2008). The glucose, lactate and pyruvate levels in blood were 
determined using standard techniques that are available in 





A total of 40 metabolites in plasma and 186 in the urine were 
analysed. Most of the metabolites, when statistically analysed, had 
no pattern in time and group and are therefore not discussed. All 
the results were analyzed as mixed repeated measures using the 
Statistical Analysis System (SAS) procedures. This method is 
described in Littell et al. (1998). If the Analysis of variance (ANOVA) 
was significant at P < 0.02 between group and time X group, the 
results were further analysed using Tukey’s test (Studentized range 
statistic) to assess if time after inoculation played a role in changes 
in metabolite concentration and if there were differences between 
specific groups. Again, only those metabolites that differed signifi-
cantly at P < 0.02 are discussed. Since the data were not normally 
distributed, the statistical analyses were done on the log-values.  
This high level of significance (P < 0.02) was chosen for two 
reasons. First, it was to markedly reduce the number of metabolites 
of interest. Second, the high level of significance will at least in part 





The values given in all the figures are the original mea-
surements. The box-plots illustrate the 25th and the 75th 
percentile as a block. The mean value is given and the 
minimum and maximum values as bars. There were no 
significant differences between the control, the Gram 
positive and the Gram negative group at time 0 in all the 
metabolites that were measured in plasma and urine. It is 
possible that ventilation with O2 may have influenced the 
metabolite profile. We believe that, if it was the case, the 
differences that we measured are still valid because the 
control group was also intubated and ventilated similar to 
the groups that were inoculated with the bacteria. 
 
 
Metabolites of interest in blood plasma 
 
α-Amino-adipic acid levels differed significantly between 
groups and in time x group (ANOVA P < 0.02 and P < 
0.002, respectively). The concentration increased signifi-
cantly at 16 and 24 h in both Gram positive and Gram 
negative baboons. No α-amino-adipic acid was measured 
in the control animals. There were no significant diffe-
rences between the plasma levels in the Gram positive 
and Gram negative groups (Figure 1). 
Both alanine and glycine differed significantly between 
groups (ANOVA P < 0.0004 and P < 0.0001, respectively)  
 







Figure 1. Changes in the levels of plasma α-amino-adipic acid (mmol/mol creatinine) over time (h) in 
the control, Gram positive and Gram negative groups (
O
P < 0.008 and P < 0.0001 at 16 and 24 h 
respectively, control versus Gram negative and *P < 0.02 and P < 0.0001 at 16 and 24 h, control 




and in time x group (ANOVA P < 0.0001 and P < 0.002, 
respectively). The control group also differed significantly 
from the experimental groups (Figures 2 and 3). 
 
 
Metabolites of interest in urine 
 
Citramalic (2-methyl malic acid), xanthurenic acid, lactic 
acid and 2-hydroxybutyric acid all differed significantly 
between groups and in time x group (ANOVA P < 0.02). 
Of these, only the changes in citramalic acid and 
xanthurenic acid are worth mentioning. Although the 
changes in the other metabolites differ significantly from 
control animals and not between Gram positive and 
Gram negative animals, the changes followed no 
distinguished pattern and will not be discussed. 
Citramalic acid and xanthurenic acid levels in urine in 
the control group were significantly less than in the 
experimental groups after 4 and 12h following ino-
culation with Gram positive and Gram negative bacteria 
(Figures 4 and 5). There were no significant differences 






It is important to note that there were no significant 
differences at time 0 in the levels of metabolites of 
interest between the three groups. The levels in the 
control group also remained almost unchanged during 
the 24 h of the study. The changes that were measured 
in the metabolites of interest in the experimental groups 
can therefore not be attributed to the anaesthesia. It is 
also reasonable to assume that the changes in meta-
bolite levels in the experimental groups can be attributed 
to inoculation of the baboons with bacteria. Also, con-
ditions such as environment, anaesthesia, fluid replace-
ment and medical care of all the animals were the same. 
This could therefore not have influenced the results 
obtained in the experimental groups. 
There were a few metabolites in plasma that showed 
promise as possible metabolic markers of early (<24 h) 
diagnosis  of  septicaemia  since  their  levels  in   plasma  
 






Figure 2. Changes in the levels of plasma alanine (mmol/mol creatinine) over time (hours) 
in the control, Gram positive and Gram negative groups (
O
P < 0.0001 at 4 to 24 h, control 




increased as early as four to eight hours after the 
baboons were infected with the bacteria. They include α-
amino-adipic acid, alanine and glycine (Figures 1 to 3). 
These findings may be of particular importance since it  is 
generally believed that current methods can only 
measure detectable levels of molecular markers after 24 
hours of infection (Jansen et al., 2000; Müller et al, 2007; 
Monneret et al., 2008; Gao et al., 2008).  
The changes in α-amino-adipic acid are of special 
interest since it could not be measured in the plasma of 
the control animals over the 24 h of the study (Figure 1). 
This is so because α-amino-adipic acid is an intermediate 
of lysine biosynthesis in bacteria (Elpeleg et al., 1990; 
Capo-Chichi et al., 2000). It is very rarely measured in 
the plasma of humans and can therefore be used as a 
differential diagnosis of septicaemia. One must bear in 
mind that α-amino-adipic acid can be formed in patients 
with an α-amino-adipic aciduria defect. This defect is very 
rare and these patients are usually diagnosed early in life 
(Fischer et al., 1974; Elpeleg et al., 1990). 
α-Amino-adipic acid, alanine and glycine cannot be 
used as markers to distinguish between Gram positive 
and Gram negative septicaemia. The changes that were 
measured over time did not differ significantly between 
the two groups infected with the bacteria (Figures 1 to 3). 
The increases over the 24 h study period strongly sug-
gest that alanine and glycine can be used as markers for 
the progression of septicaemia, at least in the early 
stages after infection since they increased during the 24 
h of the study. In this regard, alanine can be a more 
important marker since its magnitude of increase was 
larger than that of glycine (Figures 2 and 3). α-Amino-
adipic acid can also be used to monitor progression of 
septicaemia, especially at later stages (Figure 1).  
It is not certain whether the increases in α-amino-
adipic, alanine and glycine can be used to monitor the 
effectiveness of treatment, that is, will the increase over 
time be less when patients are treated? This can only be 
investigated in patients with septicaemia. Levels that 
remain constant following treatment, or even decrease, 
can indicate effectiveness of treatment. 
It is noteworthy that both citramalic acid and xanthu-
renic acid were not present in the urine of the control 
animals, but increased markedly, especially citramalic 
acid, over time in both Gram positive and Gram negative 
baboons (Figures 4 and 5). However, care must be taken  
 






Figure 3. Changes in the levels of plasma glycine (mmol/mol creatinine) over time (hours) in the control, 
Gram positive and Gram negative groups (
O
P < 0.0007 at 4 h and P < 0.0001 at 8 to 24 h, control versus 





since the increases were not as extensive as that of, for 
example, alanine in plasma (Figure 1). It is also evident 
that citramalic acid and xanthurenic acid cannot be used 
to distinguish between Gram positive and Gram negative 
bacteria, similar to those metabolites measured in the 
plasma. The increase in citramalic acid and xanthurenic 
acid levels in urine can be used as possible metabolic 
markers of progression of septicaemia (Figures 4 and 5). 
Since the differences are perhaps not as highly 
significant as, for example, alanine in plasma, care must 
be taken if these metabolites are to be used as such 
markers. Further investigation into its suitability is called 
for, simply because collection of urine is non-invasive as 
opposed to drawing blood. 
Citramalic acid is not present in the urine of baboons 
since no citramalic acid was measured in the urine of the 
control animals during the 24 h of the study (Figure 4). 
Citramalic acid is currently used as a marker for autism 
and was also identified in the cerebrospinal fluid of 
patients with bacterial meningitis (Perlman and Carr, 
1984; Shaw et al., 1995). False diagnosis of sepsis in 
autism cannot happen because of the typical behaviour 
of autism patients. Bacterial meningitis is caused by 
bacteria and this may complicate the diagnosis of sepsis 
proper if citramalic acid is also excreted in the urine of 
patients with bacterial meningitis. This underlies the 
importance that molecular markers must be used in 
conjunction with clinical symptoms and pathological 
findings (Gao et al., 2008). Citramalic acid is an inter-
mediate of the anaerobic metabolism of glutamate in 
bacteria (Howell et al., 1999). In this pathway, glutamate 
is metabolised to pyruvate and acetate (Barker, 1967). 
The significance of citramalic acid in the baboons cannot 
be established from the results of this study, but needs to 
be investigated in order to assess its use as a molecular 
marker in the diagnosis of septicaemia.  
Xanthurenic acid is rarely excreted by healthy humans. 
Xanthurenic acid is an intermediary metabolite of L-
tryptophan catabolism (Han et al., 2001) and is usually 
used as a metabolic marker of a Vitamin B6 deficiency 
(Liu et al., 1996; Anderson, 2003). The significance of 
xanthurenic  acid  in  the  urine  of  the  infected  baboons  
 






Figure 4. Changes in the urine levels of citramalic acid (mmol/mol creatinine) over time (hours) in the 
control, Gram positive and Gram negative groups (
O
P < 0.04 at 4 h, P < 0.02 at 8 h, P < 0.03 at 12 h, P < 
0.01 at 16 h, P < 0.007 at 20 h and P < 0.001 at 24 h, control versus Gram negative and *P < 0.03 at 8 h, 




needs to be established before its use as a molecular 
marker to diagnose septicaemia can be adjudged. 
The α-amino-adipic acid that was measured in the 
plasma, and citramalic acid and xanthurenic acid in the 
urine are of interest. It is formed only during septicaemia 
and was not detected in the control animals. This is 
because they are formed by the bacteria itself. Another 
important point is that these metabolites were detected 
as early as four to eight hours after inoculation. It is 
therefore not farfetched to speculate that it can be used 
to help to diagnose septicaemia at an early stage, espe-
cially if used in conjunction with one another. This should 
be tested in patients.  
It is important to keep in mind that this study must be 
regarded as a pilot study searching for such markers. 
Their specificity and sensitivity will have to be determined 
in patients. Similarly, their possible roles as indicators of 
progression of infection and as markers of the effective-
ness of treatment must be assessed in patients. Since 
infections are complex, a single marker may not be 
enough (Mueller et al., 2008) and combinations between 
molecular markers on the one hand, and/or molecular 
markers and clinical signs and symptoms and laboratory 
results needs to be investigated in order to get a 
definitive diagnosis. 
We could not distinguish between baboons infected by 
Gram positive and Gram negative bacteria by searching 
for differences in the metabolism of the animals. It may 
be that the 24 h of study was too short to manifest in a 
variable metabolic response. This will have to be tested 
in patients with septicaemia. Perhaps it is not so 
surprising that we could not distinguish differences in 
meta-bolism. The main difference between Gram positive 
and Gram negative bacteria is in their membrane 
structure (Opal and Cohen, 1999; Levy et al., 2003; Gao 
et al., 2008). We hoped that the difference in the immune 
response of the baboons to the infection could affect 
metabolism differently.  
In summary, α-amino-adipic acid, alanine and glycine in 
plasma and citramalic acid and xanthurenic acid in urine 
were identified as possible markers to be used for 
septicaemia. The fact that they also increased during the 
study strongly suggest that they may be used to assess 
progression of sepsis. One must bear in mind that these 
results were obtained in a well controlled experimental 
setup for only 24 h. Changes after  24 h  will  have  to  be  
 






Figure 5. Changes in the urine levels of xanthurenic acid (mmol/mol creatinine) over time (hours) in the 
control and Gram negative groups (
O
P < 0.03 at 12 h, P < 0.002 at 16 h, P < 0.006 at 20 and 24 h) and 
control versus Gram positive groups (*P < 0.08 at 12 h, P < 0.008 at 16 h, P < 0.003 at 20 h and P < 0.02 




assessed to give conclusive results, preferably in 
patients. None of the metabolites that were measured 
could distinguish between Gram positive and Gram nega-
tive septicaemia. This is perhaps not so surprising since 
the main difference in Gram positive and Gram negative 
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